Blood Transfusion Vs. Hydroxyurea for Stroke Prevention in Children With Sickle Cell Anemia: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Blood Transfusion Vs. Hydroxyurea for Stroke Prevention in Children With Sickle Cell Anemia: A Systematic Review and Meta-Analysis

Published:2022-11-22 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Hafiz Tamara A,Aldharman Sarah S,AlSubaie Ruby N,Alzahrani Lena D,Albalawi Ibrahim Ahmed J,Alali Yara A,Yousuf Maisaa M,Alharbi Hayat M,Alamri Nawaf S,Jamil Syed F

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference48 articles.

1. Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease;Leikin SL;Pediatrics,1989

2. Patterns of mortality in sickle cell disease in the United Kingdom;Gray A;J Clin Pathol,1991

3. The clinical features of sickle cell disease;Serjeant GR;Baillieres Clin Haematol,1993

4. Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease;Ware RE;Blood,1999

5. Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler;Adams RJ;Ann Neurol,1997

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydroxyurea for secondary stroke prevention in children with sickle cell anaemia: a systematic review of clinical evidence and outcomes;Annals of Medicine & Surgery;2024-01-03

2. Review on Hydroxyurea Usage in Young Children with Sickle Cell Disease: Examining Hemoglobin Induction, Potential Benefits, Responses, Safety, and Effectiveness;International Journal of Clinical Medicine;2024

3. Overview of the Association Between the Pathophysiology, Types, and Management of Sickle Cell Disease and Stroke;Cureus;2023-12-15